USPTO serial 79410858
SELECTAILOR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 16, 2025
- Examiner
- CROSS, TRACY L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SELECTAILOR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian P. Gregg
Brian P. Gregg McNees Wallace & Nurick100 Pine StreetHarrisburg, PA 17108United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Advertising and commercial information services; business administration and office work; marketing services; demonstration of goods; import-export agency services; business advice for companies relating to medical services and healthcare; collection of electronic data for business purposes in the field of medicine and healthcare; on-line wholesale store services featuring pharmaceuticals; on-line retail store services featuring pharmaceuticals; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; Promoting the goods of others by providing a website featuring product information in the field of pharmaceuticals; providing consumer product information via the Internet; promoting the goods and services by means of operating an on-line comprehensive shopping mall with links to the retail web sites of others; electronic data processing services relating to health care information; accountancy advice; health care cost management consultation; statistical analysis, data evaluation and preparation of business reports relating thereto in the field of healthcare. | ACTIVE | — |
| 040 | Custom manufacture of biopharmaceuticals; processing of medicinal materials; custom manufacture of pharmaceuticals; preservation of pharmaceuticals; processing of pharmaceuticals; processing of chemicals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; chemical treatment of liquids; custom manufacture of cell lines for biopharmaceutical manufacturing; custom manufacture of specific antibody-binding glycosylated drugs. | ACTIVE | — |
| 042 | Conducting early evaluations in the field of new pharmaceuticals; drug discovery services; pharmaceutical research and development; research of pharmaceuticals; pharmaceutical product evaluation; toxicity analysis for research purposes; scientific research in the nature of conducting clinical trials for others; clinical research in the field of medicine; testing services for assessing the efficiency of pharmaceuticals; analysis and evaluation of medical product development; medical research laboratories; providing information on the testing, inspection and research of medical products; medicine research; providing medical and scientific research information in the field of clinical trial progress; computer programming in the medical field; scientific research in the field of multiple nucleic acid analysis; scientific research in the field of protein analysis; biotechnology research; scientific research in the field of genetics; scientific research; scientific research in the field of molecular analysis; scientific research in the field of food; development of biotechnology; scientific research in the field of biochemical analysis; scientific research in the field of genetics and genetic engineering; biochemical research; culturing of cells for scientific research purposes; scientific research in the field of biological analysis; biochemical research; scientific research of biologics; development of pharmaceutical preparations and medicines; science laboratory services for high-efficiency glycan analysis; biological research and analysis relating to glycosylation profiles; computer software technical support service relating to troubleshooting and management support of medical image data. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Samsung Biologics Co., Ltd.
- Other trademarks owned by Samsung Biologics Co., Ltd.
- Other trademarks owned by Samsung Biologics Co., Ltd.
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named SELECTAILOR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 30, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 30, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 14, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 27, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 27, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 16, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 16, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 16, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 28, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 28, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 22, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 28, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 2, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 2, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 2, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 18, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 18, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 12, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 11, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 2, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 2, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 28, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |